Cancer Therapy News and Research

RSS

Childhood obesity: an interview with Professor Clodagh O’Gorman

Childhood obesity is harder to define than adult obesity. This is because any definition of obesity relies on measurements of both height and weight, and the calculation of body mass index (BMI) based on these measurements.

10 Dec 2012

Ex-con gets arrested on purpose in order to get health care

A 56-year-old ex-convict says he purposely got arrested for shoplifting to get prison health care for his leukemia.

10 Dec 2012

First Edition: December 10, 2012

Today's headlines include news about yesterday's "fiscal cliff" meeting between President Barack Obama and House Speaker John Boehner, as well as other health policy reports.

10 Dec 2012

Ibrutinib may effectively combat chronic lymphocytic leukemia

The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic lymphocytic leukemia (CLL), according to studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH).

10 Dec 2012

GSK, MD Anderson partner to develop new therapeutic antibodies against cancer

The University of Texas MD Anderson Cancer Center and GlaxoSmithKline (GSK) have signed a research collaboration and license agreement to develop new therapeutic antibodies that promote an immune system attack against cancer.

10 Dec 2012

Positive results from NanoString's second clinical study of PAM50-based breast cancer assay

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced positive results from the second clinical validation study of its in vitro diagnostic breast cancer assay based on the PAM50 gene expression signature.

From NanoString Technologies 7 Dec 2012

Using Nanoparticles to Target Cancer

An interview with John Stroh, discussing the development of nanoparticles that can target and treat cancer, without damaging nearby tissues.

6 Dec 2012

ASBD to host 6th Annual School of Oncoplastic Surgery in Dallas

The American Society of Breast Disease (ASBD) is merging art and medicine this week, by using clay sculpting and other techniques to teach surgeons new skills in breast cancer surgery and reconstruction.

6 Dec 2012

CPRIT announces new grants to support variety of cancer-fighting research projects in Texas

The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.

6 Dec 2012

National Radiation Oncology Registry program for quality assessment and improvement

The National Radiation Oncology Registry (NROR) pilot program will serve as the basis for the creation of a nationwide electronic registry to capture reliable, population-based information on radiation treatment delivery and health outcomes and will be supported by an innovative information technology (IT) infrastructure that will maximize efficiency through the automated collection and electronic transfer of data, according to research presented at the American Society for Clinical Oncology (ASCO) Quality Care Symposium.

5 Dec 2012

Arthrobotrys oligospora produces nanoparticles that could kill tumors

Arthrobotrys oligospora doesn't live a charmed life; it survives on a diet of roundworm. But a discovery by a team led by Mingjun Zhang, an associate professor of biomedical engineering at the University of Tennessee, Knoxville, could give the fungus's life more purpose-as a cancer fighter.

5 Dec 2012

Certain patients with prostate cancer may benefit from Provenge clinical trial

Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.

4 Dec 2012

Enzalutamide shows promise in treating triple-negative and estrogen-positive breast cancer

Breast cancers are defined by their drivers - estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer treatment options - this aggressive form of breast cancer without ER, PR or HER2, which was thought not to be driven by hormones, is known as triple negative.

3 Dec 2012

Specific transporters could be exploited to deliver toxic substances into cancer cells

Whitehead Institute scientists report that certain molecules present in high concentrations on the surfaces of many cancer cells could be exploited to funnel lethal toxic molecules into the malignant cells. In such an approach, the overexpression of specific transporters could be exploited to deliver toxic substances into cancer cells.

3 Dec 2012

Scientists determine how two proteins help create organelles

Scientists at The Scripps Research Institute (TSRI) have determined how two proteins help create organelles, or specialized subunits within a cell, that play a vital role in maintaining cell health. This discovery opens the door for research on substances that could interfere with the formation of these organelles and lead to new therapies for cancer.

2 Dec 2012

Weak economic situation will affect health of ageing population, researchers warn

Many people will be much poorer than they had expected in their older age and this has profound implications for the health of our ageing population claims an editorial published today in Age & Ageing, the scientific journal of the British Geriatrics Society.

1 Dec 2012

Delaying treatment affects mortality rates among women with breast cancer

Results from a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) show women who wait more than 60 days to begin treatment for advanced breast cancer face significantly higher risks of dying than women who start therapy shortly after diagnosis.

30 Nov 2012

Clinical trial shows effectiveness of ponatinib in patients with leukemia and lymphoma

Huntsman Cancer Institute researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard treatments for chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic lymphoma.

30 Nov 2012

Rural cancer survivors more likely to have poor health outcomes

Cancer survivors who live in rural areas are more likely to say they are in poor health than those who live in urban areas, according to a study in the journal Cancer. They are also more likely to have other health disorders, more psychological distress, and be unemployed due to health reasons than city dwellers.

30 Nov 2012

Diabetes education critical for uncontrolled high blood sugar people with cancer

When people with Type 2 diabetes are diagnosed with cancer -- a disease for which they are at higher risk -- they ignore their diabetes care to focus on cancer treatment, according to new Northwestern Medicine- research. But uncontrolled high blood sugar is more likely to kill them and impairs their immune system's ability to fight cancer.

30 Nov 2012

Cancer Therapy News and Research

Childhood obesity: an interview with Professor Clodagh O’Gorman

Ex-con gets arrested on purpose in order to get health care

First Edition: December 10, 2012

Ibrutinib may effectively combat chronic lymphocytic leukemia

GSK, MD Anderson partner to develop new therapeutic antibodies against cancer

Positive results from NanoString's second clinical study of PAM50-based breast cancer assay

Using Nanoparticles to Target Cancer

ASBD to host 6th Annual School of Oncoplastic Surgery in Dallas

CPRIT announces new grants to support variety of cancer-fighting research projects in Texas

National Radiation Oncology Registry program for quality assessment and improvement

Arthrobotrys oligospora produces nanoparticles that could kill tumors

Certain patients with prostate cancer may benefit from Provenge clinical trial

Enzalutamide shows promise in treating triple-negative and estrogen-positive breast cancer

Specific transporters could be exploited to deliver toxic substances into cancer cells

Scientists determine how two proteins help create organelles

Weak economic situation will affect health of ageing population, researchers warn

Delaying treatment affects mortality rates among women with breast cancer

Clinical trial shows effectiveness of ponatinib in patients with leukemia and lymphoma

Rural cancer survivors more likely to have poor health outcomes

Diabetes education critical for uncontrolled high blood sugar people with cancer

Your guide to microplate readers for cancer research eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News